CareCloud, Inc. (CCLD)

NASDAQ: CCLD · USD

$1.77

+0.03 (+1.7%)· Recorded snapshot

Market cap	75.2M
Revenue (ttm)	128.6M
Net income (ttm)	3M
EPS (ttm)	$0.07
Shares out	42.5M
P/E (trailing)	25.4x
P/E (forward)	6.5x
Volume	189,458
Beta	1.51

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 128.6M
Net income (ttm): 3M
EPS (ttm): $0.07
P/E (trailing): 25.4x
P/E (forward): 6.5x
Market cap: 75.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E6.5

P25 n/aP50 n/aP75 n/a

Trailing P/E25.4

P25 n/aP50 n/aP75 n/a

ROE21.8

P25 n/aP50 n/aP75 n/a

ROIC15

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CCLD indicators

Market & fundamental data

Available fields

249

Groups with data

Currency

USD

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001582982
Company name	CareCloud, Inc.
Country	United States
Country code	US
CUSIP number	14167R100
Earnings date	2026-11-05
Earnings time	bmo
Employees	3,650
Employees change	50
Employees growth	1.39%
Enterprise value	$115.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1999
Industry	Health Information Services
IPO date	2014-07-23
Is primary listing	Yes
Is SPAC	No
ISIN number	US14167R1005
Last 10-K release date	2026-03-12
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$75.2M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$1.77
Price currency	USD
Sector	Healthcare
SIC code	7372
Stock price date	2026-10-28
Symbol	CCLD
U.S. state	New Jersey
Website	https://www.carecloud.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	5.53x
Earnings yield	3.93%
EV/Earnings	38.61x
EV/EBIT	12.37x
EV/EBITDA	7.55x
EV/FCF	5.01x
EV/Sales	0.89x
FCF / EV yield	19.97%
FCF yield	31.01%
Forward EV/Sales	0.85x
Forward P/E	6.55x
Forward P/S	0.55x
Graham number	0.80076
Graham upside	-53.71%
Industry forward P/E	35.4x
P/(FCF - SBC) ratio	3.28x
P/(OCF - SBC) ratio	2.79x
P/B ratio	4.25x
P/E ratio	25.43x
P/FCF ratio	3.23x
P/OCF ratio	2.75x
P/S ratio	0.57x
Price/EBITDA ratio	4.86x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7.18%
EBITDA margin	11.75%
Effective tax rate	3.27%
FCF margin	17.72%
Gross margin	46.5%
Operating margin	7.18%
Pretax margin	6.42%
Profit margin	6.21%
Profit per employee	$810
Profitable quarters	1
Profitable years	1
Revenue per employee	$35,244
ROA	6.82%
ROA (5Y)	3.58%
ROCE	15.29%
ROE	21.75%
ROE (5Y)	-4.53%
ROIC	15.04%
ROIC (5Y)	8.17%
SBC / revenue	0.28%
Tax / revenue	0.21%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-88.27%
EPS growth years	2
FCF growth	4.76%
FCF growth (Q)	4.84%
FCF growth (QoQ)	104.69%
FCF growth 3Y	9.85%
FCF growth 5Y	92.56%
Gross profit growth	16.32%
Gross profit growth (Q)	11.83%
Gross profit growth 3Y	6.12%
Gross profit growth 5Y	3.56%
Net income growth	-29.07%
Net income growth (Q)	-61.34%
Net income growth years	2
OCF growth	7.68%
OCF growth (Q)	-4.52%
OCF growth (QoQ)	95.87%
OCF growth 3Y	9.36%
OCF growth 5Y	45.37%
Operating income growth	-23.28%
Operating income growth (Q)	-39.45%
Operating income growth 3Y	494.18%
Revenue growth	15.07%
Revenue growth (Q)	16.45%
Revenue growth (QoQ)	1.95%
Revenue growth 10Y	19.7%
Revenue growth 3Y	0.8%
Revenue growth 5Y	0.18%
Revenue growth quarters	4
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-3.9M
Depreciation and amortization	$5.9M
EBIT	$9.2M
EBITDA	$15.1M
EPS	$0.07
FCF per share	$0.54
Financing cash flow	$407,000
Free cash flow	$22.8M
Free cash flow minus SBC	$22.4M
Gross profit	$59.8M
Income taxes	$270,000
Investing cash flow	$-24.3M
Net borrowing	$48.7M
Net cash flow	$3M
Net income	$3M
Operating cash flow minus SBC	$26.4M
Operating income	$9.2M
Revenue	$128.6M
Stock-based compensation	$363,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.86
Book value per share	$0.41
Debt / EBITDA	3.13
Debt / equity	3.1
Debt / FCF	2.37
Goodwill	$31.8M
Interest coverage	8.93
Long-term assets	$59.7M
Long-term liabilities	$43M
Net cash (debt)	$-40.6M
Net cash / market cap	-55.25%
Net debt / EBITDA	2.69
Net debt / equity	2.33
Net debt / FCF	1.78
Piotroski F-Score	6
Property, plant and equipment	$12.1M
Shareholders' equity	$17.4M
Tangible book value	$-29.4M
Tangible book value per share	$-0.69
Total assets	$93.8M
Total cash	$13.4M
Total debt	$54M
Total liabilities	$76.4M
WACC	8.02%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.52
Current assets	$34.2M
Current liabilities	$33.5M
Current ratio	1.02
Inventory turnover	138.47
Net working capital	$-371,000
Quick ratio	0.92
Working capital	$695,000
Working capital turnover	16.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-72.17%
Dividend yield	0%
Shareholder yield	-72.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	110.71%
10Y return CAGR	7.74%
10Y total return	110.71%
150-day SMA	$2.40
1D price change	1.72%
1M price change	-13.66%
1M total return	-13.66%
1Y price change	-43.09%
1Y return CAGR	-43.11%
1Y total return	-43.09%
20-day SMA	$1.89
200-day SMA	$2.50
3M price change	-20.63%
3M total return	-20.63%
3Y price change	88.32%
3Y return CAGR	23.48%
3Y total return	88.32%
50-day SMA	$2.10
50-day SMA vs 200-day SMA	50under200
52-week high	$3.81
52-week high date	2026-03-26
52-week low	$1.70
52-week low date	2026-10-26
5Y price change	-76.77%
5Y return CAGR	-25.32%
5Y total return	-76.77%
6M price change	-45.71%
6M total return	-45.71%
All-time high	$13.40
All-time high date	2020-08-07
All-time low	$0.29
All-time low date	2017-04-24
Average true range (ATR)	$0.09
Average volume	224.5K
Beta (1Y)	-0.24
Beta (2Y)	1.63
Beta (5Y)	1.51
Change from 52-week high	-53.54%
Change from 52-week low	4.12%
Change from all-time high	-86.79%
Change from all-time low	510.34%
Change from open	-3.28%
Day's gap	5.17%
Dollar volume	$335,341
High price	$1.83
Low price	$1.73
Monthly RSI	42.66
Open price	$1.83
Position in 52-week range	40%
Premarket change	0.57%
Premarket close	$1.74
Premarket price	$1.75
Previous close	$1.74
Price vs 150-day SMA	-26.31%
Price vs 20-day SMA	-6.15%
Price vs 200-day SMA	-29.09%
Price vs 50-day SMA	-15.83%
Relative volume	0.86
RSI	38.01
Sharpe ratio	-0.66
Sharpe ratio (3Y)	0.61
Sharpe ratio (5Y)	0.06
Sortino ratio	-0.87
Sortino ratio (3Y)	1.13
Sortino ratio (5Y)	0.17
Volume	189.5K
Weekly RSI	34.57
YTD price change	-39.38%
YTD total return	-39.38%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36.1M
Float percentage	84.99%
Shares change (QoQ)	0.05%
Shares change (YoY)	72.17%
Shares held by insiders	15.01%
Shares held by institutions	22.75%
Shares outstanding	42.5M
Short % of float	1.81%
Short % of shares	1.54%
Short ratio	2.5 days

Deeper analysis on CCLD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CCLD report

Is a complete CCLD research report available?

No complete published report is available for CareCloud, Inc. (CCLD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CareCloud, Inc. (CCLD)

Price

Financial snapshot

Fair-value bridge

Latest news · CCLD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CCLD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CCLD

Frequently asked questions